← Back to Medler Ferro Woodhouse & Mills Pllc
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19544916 | FLUORESCENCE IMAGING SYSTEM FOR WOUNDS | Ekare Inc. | SABOKTAKIN, MARJAN | 3797 | §103 | Final Rejection | — | Pending | Feb 19, 2026 |
| 19433400 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND A PROCESS FOR PREPARATION | Pharmazz, Inc. | BERHANE, SELAM | 1675 | §102 | Non-Final OA | — | Pending | Dec 26, 2025 |
| 19489804 | WHEEL SUSPENSION FOR A MOTOR VEHICLE | Muhr Und Bender Kg | TO, TOAN C | 3614 | §112 | Non-Final OA | — | Pending | Dec 03, 2025 |
| 19482917 | CONTROLLER FOR A MILKING PLANT, COMPUTER-IMPLEMENTED METHOD, COMPUTER PROGRAM AND NON-VOLATILE DATA CARRIER | Delaval Holding AB | DENNIS, KEVIN M | 3647 | §102§103§112 | Non-Final OA | — | Pending | Nov 10, 2025 |
| 19228139 | RESOURCE-SAVING CLOSURE DEVICE | BERICAP Holding GmbH | SMALLEY, JAMES N | 3733 | §102§103§112 | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19223202 | Milking Robot Controller, Method therefore, Computer Program and Non-Volatile Data Carrier | Delaval Holding AB | NGUYEN, ROBERT T | 3642 | §103§112 | Non-Final OA | — | Pending | May 30, 2025 |
| 19123637 | DEHUMIDIFYING SYSTEM | Munters Europe Aktiebolag | VAZQUEZ, ANA M | 3763 | §103 | Non-Final OA | — | Pending | Apr 23, 2025 |
| 19181886 | DEVICE, SYSTEM AND METHOD FOR INSPECTING THREE-DIMENSIONAL OBJECTS | Isra Vision GmbH | KO, TONY | 2878 | §112 | Non-Final OA | — | Pending | Apr 17, 2025 |
| 19120100 | MEDICAL ENDODEVICE | UNIVERSITÄT BASEL | SAHAND, SANA | 3796 | §101§103§112 | Non-Final OA | — | Pending | Apr 10, 2025 |
| 19114020 | METHOD FOR MANUFACTURING A DENTAL PROSTHESIS PART, ADAPTER, BLANK AND SET OF ADAPTER AND BLANK, SET OF SEVERAL ADAPTERS | Ceramist One GmbH | LUCCHESI, NICHOLAS D | 3772 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2025 |
| 18985583 | ENDOSCOPE WITH INERTIAL MEASUREMENT UNITS AND/OR HAPTIC INPUT CONTROLS | Elements Endoscopy Inc. | WOO, JAE KYUN | 3795 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18872988 | EVALUATION OF CONVERGENCE TIME AND ADJUSTMENT BASED ON EVALUATION OF CONVERGENCE TIME | Mercedes-Benz Group AG | BEDEWI, RAMI NABIH | 3666 | §101§102§103 | Final Rejection | 84d | Pending | Dec 09, 2024 |
| 18971848 | ANTI-CLAUDIN-6 CONJUGATES | Adc Therapeutics SA | PETRASH, HILARY ANN | 1644 | §103DP | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18969940 | ANTI-PSMA ANTIBODY CONJUGATES | Adc Therapeutics SA | PETRASH, HILARY ANN | 1644 | §103Other | Non-Final OA | 41d | Pending | Dec 05, 2024 |
| 18957184 | TESTOSTERONE AND ESTRADIOL TRANSDERMAL SPRAY | Celista Pharmaceuticals LLC | SONG, JIANFENG | 1613 | §103§112DP | Non-Final OA | — | Pending | Nov 22, 2024 |
| 18946353 | INFORMATION PROCESSING METHOD, NON-TRANSITORY STORAGE MEDIUM, AND INFORMATION PROCESSING APPARATUS | Tsz Tat Chu | MAHROUKA, WASSIM | 2665 | §101§103§112 | Non-Final OA | — | Pending | Nov 13, 2024 |
| 18938929 | QUALITY CONTROL METHODS FOR AUTOMATED CELL PROCESSING | Lonza Walkersville, Inc. | WESTON, ALYSSA G | 1633 | §103§112DP | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18860366 | COMBINATION OF ALBUTEROL AND BUDESONIDE FOR THE TREATMENT OF ASTHMA | AstraZeneca AB | YOUNG, MICAH PAUL | 1618 | §102§103 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18923071 | COMPACT MIXED ARRAY IMAGING PROBE | Deepsight Technology, Inc. | FARAG, AMAL ALY | 3798 | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18889738 | TREATMENT APPARATUS AND METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR THE LASER-INDUCED REFRACTIVE INDEX CHANGE | Schwind Eye-Tech-Solutions GmbH | FAIRCHILD, MALLIKA DIPAYAN | 3792 | §101 | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18886028 | MULTI-USE ENDOSCOPES AND ASSOCIATED SYSTEMS AND METHODS | Elements Endoscopy, Inc. | LONDON, STEPHEN FLOYD | 3795 | §102§103§112DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18841618 | TOPICAL COMPOSITIONS AND USES THEROF | Topadur Pharma AG | SHTERENGARTS, SAMANTHA L | 1623 | §103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18840561 | SAMPLE PREPARATION FOR GLYCOPROTEOMIC ANALYSIS THAT INCLUDES DIAGNOSIS OF DISEASE | VENN BIOSCIENCES CORPORATION | FRANK, RODNEY T | 2855 | §103§112 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18798864 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Entera Bio Ltd. | PALENIK, JEFFREY T | 1615 | §103 | Final Rejection | — | Pending | Aug 09, 2024 |
| 18798508 | GUANINE-RICH OLIGONUCLEOTIDES | Kuros US LLC | CROW, ROBERT THOMAS | 1683 | §103§112 | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18836057 | PHARMACEUTICAL COMPOSITION OF LIFITEGRAST AND LOTEPREDNOL ETABONATE | Orbicular Pharmaceutical Technologies Private Limited | RICCI, CRAIG D | §102§103§112 | Non-Final OA | — | Pending | Aug 06, 2024 | |
| 18835518 | 3-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS | Aurigene Discovery Technologies Limited | BURKETT, DANIEL JOHN | 1624 | §102§112 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18780030 | METHODS OF CELL SELECTION AND MODIFYING CELL METABOLISM | LONZA LTD | PAK, YONG D | 1652 | §103§112 | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18776688 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | HOUGH, JESSANDRA F | 3796 | §101§103 | Non-Final OA | 29d | Pending | Jul 18, 2024 |
| 18772698 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS, CONTROL DEVICE THEREFOR, TREATMENT APPARATUS, COMPUTER PROGRAM PRODUCT AND COMPUTER-READABLE MEDIUM | Schwind Eye-Tech-Solutions GmbH | MARSH, OWEN LEWIS | 3796 | §101§102§103§112 | Non-Final OA | 29d | Pending | Jul 15, 2024 |
| 18728675 | FUNCTIONALIZED AMINOTHIAZOLES | Leadxpro AG | REDWOOD, CHRISTOPHER EVAN | 1629 | §103 | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18771844 | SECURE RECONSTITUTION DEVICE | Duoject Medical Systems Inc. | DEAK, LESLIE R | 3799 | DP | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18769485 | Midscale Model For Organic Growth and Phasing | LONZA LTD | KIPOUROS, HOLLY MICHAELA | 1799 | §102§112 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18766913 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | HILSMIER, HEIDI ANN | 3796 | §101§102§103 | Non-Final OA | 34d | Pending | Jul 09, 2024 |
| 18762112 | TOPICAL FORMULATIONS AND USES THEREOF | Sun Pharmaceutical Industries, Ltd. | KASSA, TIGABU | §101§103§112Other | Non-Final OA | — | Pending | Jul 02, 2024 | |
| 18724799 | SELF-ADMINISTRATION INJECTION DEVICE FOR RISPERIDONE | Orbicular Pharmaceutical Technologies Private Limited | WHITROCK, ZACHARIAH KIRBY | 3783 | §103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18754402 | CELL CULTURE AND TISSUE ENGINEERING SYSTEMS WITH CONTROLLED ENVIRONMENTAL ZONES | Octane Biotech Inc. | HENKEL, DANIELLE B | 1799 | §102§103§112 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18721640 | METHOD FOR MANUFACTURING AN ARRANGEMENT FOR CONDENSING A GASEOUS LIQUID INTO LIQUID STATE | Aktiebolaget Scarab Development | GROSS, CARSON | 1746 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18721646 | ARRANGEMENT AND PLATE FOR CONDENSING A GASEOUS LIQUID INTO LIQUID STATE | Aktiebolaget Scarab Development | BUI, ANH HUYNH NGOC | 1773 | §102§103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18720675 | PROSTATE CANCER CLINICAL STATUS MARKERS | UNIVERSITAET ZUERICH | IVICH, FERNANDO NMN | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18680666 | INTRALUMINAL LOCAL DRUG DELIVERY | Isola Therapeutics, Inc. | SCHMIDT, EMILY LOUISE | 3783 | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18678376 | DNA-BASED ADAPTOME PROFILING FOR MINIMAL RESIDUAL DISEASE QUANTIFICATION IN LYMPHOID MALIGNANCIES | Milaboratories Inc. | BROWN, MINDY G | 1683 | §112 | Non-Final OA | 16d overdue | Pending | May 30, 2024 |
| 18675357 | CELLULOSIC COMPOSITE | Woodcomposite Sweden AB | NERANGIS, VICKEY M | 1763 | §103Other | Non-Final OA | 33d | Pending | May 28, 2024 |
| 18675209 | CELLULOSIC COMPOSITE | Woodcomposite Sweden AB | NERANGIS, VICKEY M | 1763 | §103 | Non-Final OA | 75d | Pending | May 28, 2024 |
| 18706231 | TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME | Targimmune Therapeutics AG | FAY, ZOHREH ALEMZADEH | 1617 | §112Other | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18705455 | SPRAY-DRIED COMPOSITIONS AND METHODS OF PREPARATION | National University Of Singapore | PEEBLES, KATHERINE | 1617 | §103§112 | Final Rejection | 34d | Pending | Apr 26, 2024 |
| 18705292 | MICROFLUIDIC CELL CULTURING DEVICE | UNIVERSITÄT BERN | BRIDGES, DONAVAN LEE | 1758 | §102§103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18645797 | METHOD FOR PROVIDING CONTROL DATA FOR A LASER OF A PROCESSING APPARATUS, CONTROL DEVICE, COMPUTER PROGRAM AND COMPUTER-READABLE MEDIUM | Schwind Eye-Tech-Solutions GmbH | SANDERS, JOSHUA T | 2119 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18700883 | SLEEP-BASED DETECTION AND INTERVENTION SYSTEM | UNIVERSITÄT BERN | DIETZ, NOE ROBERT | 3791 | §102§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18633844 | PD-1/TIGIT BINDING PROTEINS FOR CANCER TREATMENT | MedImmune, LLC | ALLEN, MARIANNE P | 1647 | §103§112Other | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18632522 | R-FADROZOLE FOR USE IN THE TREATMENT OF ALDOSTONERISM | Damian Pharma AG | ROZOF, TIMOTHY R | 1625 | DP | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18631297 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER OF A TREATMENT APPARATUS FOR AVOIDING AN OPAQUE BUBBLE LAYER | Schwind Eye-Tech-Solutions GmbH | LEVICKY, WILLIAM J | 3796 | §102§103 | Final Rejection | 45d overdue | Pending | Apr 10, 2024 |
| 18699059 | ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS | UNIVERSITY OF OTTAWA | NATARAJAN, MEERA | 1643 | §112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18698193 | ULTRASOUND BEACON VISUALIZATION WITH OPTICAL SENSORS | Deepsight Technology, Inc. | KLEIN, BROOKE L | 3797 | §102§103 | Final Rejection | — | Pending | Apr 03, 2024 |
| 18604899 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER | Schwind Eye-Tech-Solutions GmbH | LEE, ERICA SHENGKAI | 3796 | §101§102 | Non-Final OA | 61d | Pending | Mar 14, 2024 |
| 18444169 | DEVICES AND SYSTEMS FOR INTRALUMINAL LOCAL DRUG DELIVERY | Isola Therapeutics, Inc. | BRANDT, DAVID NELSON | 3783 | §103§112Other | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18683932 | STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF | Sun Pharmaceutical Industries, Ltd. | BECKHARDT, LYNDSEY MARIE | 1613 | §103§112Other | Final Rejection | 70d | Pending | Feb 15, 2024 |
| 18427293 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF | MedImmune, LLC | PUTTLITZ, KARL J | 1642 | §112DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18292730 | ELECTRONIC CONVERSION KIT FOR A MOTOR VEHICLE IN WHICH AN INTERNAL COMBUSTION ENGINE IS EXCHANGED FOR AN ELECTRIC TRACTION DRIVE HAVING AN ELECTRIC MOTOR, MOTOR VEHICLE HAVING THE CONVERSION KIT AND OPERATING METHOD FOR THE CONVERSION KIT | E-R3Volt GmbH | WANG, HARRY Z | 2184 | §103 | Non-Final OA | 15d overdue | Pending | Jan 26, 2024 |
| 18292242 | MEDICAL DELIVERY DEVICE | Hoffmann-La Roche, Inc. | FORD, RENE D | 3741 | §102§112 | Final Rejection | 40d | Pending | Jan 25, 2024 |
| 18291725 | TEAR-OPEN STRIP FOR A PACKAGING AND METHOD FOR PRODUCING A TEAR-OPEN STRIP | Mayr-Melnhof Karton AG | ZHANG, MICHAEL N | 1781 | §103 | Non-Final OA | 32d overdue | Pending | Jan 24, 2024 |
| 18291326 | HANDHELD GYNECOLOGICAL DEVICE, HANDLE AND ROD MEMBER | Aspivix SA | LONG, SARAH A | 3771 | §103 | Final Rejection | — | Pending | Jan 23, 2024 |
| 18577945 | PHARMACEUTICAL COMPOSITIONS OF A B7-H3 ANTIBODY AND USE OF THE SAME | Macrogenics, Inc. | NATARAJAN, MEERA | 1643 | §102§112 | Non-Final OA | — | Pending | Jan 09, 2024 |
| 18403384 | SHARED ELECTRIC BIKE WITH INTEGRATED FRAME AND LAMPS | VEORIDE INC. | LEE, MATTHEW D | 3617 | §102§103 | Final Rejection | 11d overdue | Pending | Jan 03, 2024 |
| 18394869 | HER2/neu-Specific Antibodies and Methods of Using Same | Tersera Therapeutics LLC | NATARAJAN, MEERA | 1643 | §103DP | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18391131 | CENTERING DEVICE FOR DETERMINING A CENTERING OF A VISUAL AXIS OF AN EYE | Schwind Eye-Tech-Solutions GmbH | BAIG, RUMAISA RASHID | 3796 | §103 | Non-Final OA | 24d overdue | Pending | Dec 20, 2023 |
| 18572508 | COMPOSITION FOR DETECTING MICROBIAL ON-SITE CONTAMINATION AND USE THEREOF | BIONANO HEALTH GUARD RESEARCH CENTER | GOLDBERG, JEANINE ANNE | 1682 | §102§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18572300 | COMBINATION THERAPY USING ANTIBODY-DRUG CONJUGATES | MedImmune, LLC | PETERS, ALEC JON | 1641 | §103§112DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18545392 | NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS | UNIVERSITÄT BERN | LEE, JIA-HAI | 1658 | §102§103§112DP | Final Rejection | — | Pending | Dec 19, 2023 |
| 18571164 | PRPF31 VARIANT AND USES THEREOF | Chigenovo Co., Ltd. | YU, DAVID TUYANG | 1635 | §103§112 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18539883 | METHOD FOR PROVIDING CONTROL DATA FOR AN OPHTHALMOLOGICAL LASER FOR PROVIDING A TRANSITION ZONE BETWEEN INTERFACES | Schwind Eye-Tech-Solutions GmbH | MALAMUD, DEBORAH LESLIE | 3792 | §101§102 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18533836 | METHOD FOR ISOLATING NUCLEIC ACIDS FROM A FORMALDEHYDE RELEASER STABILIZED SAMPLE | Qiagen GmbH | CROW, ROBERT THOMAS | 1683 | §103 | Final Rejection | — | Pending | Dec 08, 2023 |
| 18557748 | APPLICATION OF ARTIFICIALLY SYNTHESIZED CPG SINGLE-STRANDED DEOXYOLIGONUCLEOTIDE IN VACCINES | Parr Biotechnology (Hebei) Co., Ltd. | ZOU, NIANXIANG | 1671 | §102§103§112DP | Final Rejection | — | Pending | Dec 01, 2023 |
| 18561525 | REDOX SENSITIVE CRALBP MUTANT PROTEINS | UNIVERSITÄT BERN | BREEN, KIMBERLY CATHERINE | 1657 | §112 | Final Rejection | — | Pending | Nov 16, 2023 |
| 18502863 | TOPICAL OXYBUTYNIN FOR HOT FLASHES | Celista Pharmaceuticals LLC | BRAM, STANLEY | 1691 | §102§103§112 | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18499658 | METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH PD-1 AND CTLA-4 | Macrogenics, Inc. | MOSELEY II, NELSON B | 1642 | §112DP | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18557414 | TRANSGENIC RODENTS EXPRESSING CHIMERIC EQUINE-RODENT ANTIBODIES AND METHODS OF USE THEREOF | Trianni, Inc. | SINGH, ANOOP KUMAR | 1632 | §102§112 | Non-Final OA | 84d | Pending | Oct 26, 2023 |
| 18556287 | FUNCTIONALIZED BIOCATALYTICAL COMPOSITIONS | Perseo Pharma AG | SHOMER, ISAAC | 1612 | §103DP | Non-Final OA | 10d overdue | Pending | Oct 19, 2023 |
| 18484921 | MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | Macrogenics, Inc. | BRISTOL, LYNN ANNE | 1643 | §103§112Other | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18554935 | MODIFIED VIRUS-LIKE PARTICLES OF BACTERIOPHAGE AP205 | Saiba AG | HILL, MYRON G | 1671 | §103 | Final Rejection | 4d overdue | Pending | Oct 11, 2023 |
| 18286301 | LAYER COMPOSITE FOR USE AS AN IMITATION LEATHER | Nuvi Releaf GmbH | SALVATORE, LYNDA | 1789 | §103 | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18478528 | LYOPHILIZED SOVATELTIDE-BASED INJECTABLE FORMULATION AND METHOD FOR PREPARATION THEREOF | Pharmazz, Inc. | D' AMBROSIO, THEA | 1654 | §103§112Other | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18553010 | CONTROL OF AN ENERGY STORAGE ARRANGEMENT | Martin Huber | MURALIDAR, RICHARD V | 2859 | §102§103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18373470 | EDGE PROTECTION MOUNTING DEVICE IN A SYSTEM FOR SHEET COIL PACKAGING | Lamiflex Group AB | HIBBERT, MARY C | 3731 | §101§112DP | Non-Final OA | — | Pending | Sep 27, 2023 |
| 18552778 | EXTRACELLULAR VESICLE COMPOSITIONS | Lonza Sales AG | MCKILLOP, JOHN CHARLES | 1637 | §103§112 | Final Rejection | — | Pending | Sep 27, 2023 |
| 18552468 | VARIANTS OF RHIZOMUCOR MIEHEI LIPASE AND USES THEREOF | Wilmar International Limited | KANE, TREVOR LOGAN | 1657 | §102§103§112 | Final Rejection | 9d overdue | Pending | Sep 26, 2023 |
| 18552338 | MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS | Iosbio Ltd. | LY, KRISTINA ELISABETH | 1671 | §102§103§112 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18549629 | ANTIBODIES AGAINST TDP-43 AND METHODS OF USING THE SAME | UNIVERSITY OF ZURICH | NICKOL, GARY B | 1643 | §101§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18462800 | METHOD FOR PRODUCING BIOLOGIC PRODUCT VARIANTS | LONZA LTD | MIANO, JOSEPH PAUL | 1631 | §101§102§103 | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18548738 | DEVICE FOR MODELLING A BLOOD LABYRINTH BARRIER | UNIVERSITÄT BASEL | CARREON, ADRIAN JOHN | 1799 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18454930 | CARBON-SOURCE REGULATED PROTEIN PRODUCTION IN A RECOMBINANT HOST CELL | LONZA LTD | MEAH, MOHAMMAD Y | 1652 | §103§112DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18237675 | 4-THIOCARBAMOYLPHENYL 2-(4-OXOPHENYL)-PHENYL PROPANOATE FOR THE TREATMENT OF PAIN ASSOCIATED WITH UROLOGIC CHRONIC PELVIC PAIN SYNDROME | Antibe Therapeutics Inc. | HIRAKIS, SOPHIA P | 1623 | §102§112DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18264332 | TREATMENT OF SKIN DISORDERS | BACOBA AG | BANERJEE, KOYELI | 1654 | §103§112 | Non-Final OA | — | Pending | Aug 04, 2023 |
| 18354770 | CELL CULTURE CHAMBER FOR INCREASED CELL YIELD | Octane Biotech Inc. | MUTREJA, JYOTI NAGPAUL | 1798 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18261934 | PROCESS FOR PREPARING METAL OXIDE NANOSHEETS | Royal Melbourne Institute Of Technology | NGUYEN, CAM N | 1736 | §103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18272961 | SET OF CHEMICALS FOR THE PREPARATION OF A POLYMER | Chemische Fabrik Budenheim Kg | JOHNSTON, BRIEANN R | 1766 | §102§103§112 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18343087 | PHARMACEUTICAL FORMULATION FOR TREATMENT OF CEREBRAL STROKE | Pharmazz, Inc. | HOWARD, ZACHARY C | 1674 | §103§112Other | Final Rejection | 22d overdue | Pending | Jun 28, 2023 |
| 18343296 | METHOD FOR ISOLATING RNA WITH HIGH YIELD | Qiagen GmbH | OLSON, ANDREA STEFFEL | 1693 | §103Other | Final Rejection | 4d overdue | Pending | Jun 28, 2023 |
| 18342845 | SUSTAINABLE PROCESS FOR PREPARATION OF PHOSPHORIC MONOESTERS AND SALTS THEREOF | Galaxy Surfactants Ltd. | AGGARWAL, SAHIL CHANDER | 1623 | §103 | Final Rejection | — | Pending | Jun 28, 2023 |
| 18258684 | CHARGING DEVICE AND METHOD FOR CHARGING AN ELECTRICAL STORED ENERGY SOURCE OF AN ELECTRICALLY OPERABLE VEHICLE | Brusa Technology AG | KIK, PHALLAKA | 2851 | §102 | Non-Final OA | — | Pending | Jun 21, 2023 |
| 18268933 | Composition Comprising Calcium Orthophosphate and a Bioactive Glass Comprising Fluorine | Queen Mary University Of London | LIU, TRACY | 1614 | §103 | Final Rejection | 38d overdue | Pending | Jun 21, 2023 |
| 18258501 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | Prime Vector Technologies Gmby | HILL, MYRON G | 1671 | §102§103§112 | Final Rejection | 79d overdue | Pending | Jun 20, 2023 |
| 18258502 | MODIFIED PARAPOXVIRUS HAVING INCREASED IMMUNOGENICITY | Prime Vector Technologies GmbH | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §101§102§103§112 | Final Rejection | 98d overdue | Pending | Jun 20, 2023 |
| 18257749 | ANTI-BCMA ANTIBODY, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Wuhan Yzy Biopharma Co., Ltd. | SAOUD, CHRISTINE J | 1645 | §112 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18331573 | MATERIAL PROCESSING APPARATUS AND METHOD FOR PREPARING A MATERIAL PROCESSING APPARATUS | Schwind Eye-Tech-Solutions GmbH | WIBLIN, MATTHEW | 3745 | §102§112 | Non-Final OA | — | Pending | Jun 08, 2023 |
| 18255525 | HEAVY CHAIN-ONLY ANTIBODIES | Trianni, Inc. | WILSON, MICHAEL C | 1638 | §112 | Final Rejection | 2d overdue | Pending | Jun 01, 2023 |
| 18321354 | Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of Disease | Macrogenics, Inc. | MOSELEY II, NELSON B | 1642 | DP | Non-Final OA | — | Pending | May 22, 2023 |
| 18253853 | NUCLEIC ACID DUPLEXES | Alpha Anomeric SAS | GROOMS, TIFFANY NICOLE | 1637 | §112 | Non-Final OA | — | Pending | May 22, 2023 |
| 18320599 | TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS | Macrogenics, Inc. | BRISTOL, LYNN ANNE | 1643 | §112Other | Non-Final OA | 23d overdue | Pending | May 19, 2023 |
| 18197975 | FIRE EXTINGUISHER, A SYSTEM FOR MONITORING A FIRE EXTINGUISHER, AND METHODS FOR DETECTING LEAKAGE FROM A FIRE EXTINGUISHER | Cosesy A/S | LIEUWEN, CODY J | 3752 | §103 | Non-Final OA | 8d | Pending | May 16, 2023 |
| 18253160 | ADJUVANT CONTAINING ZINC ALUMINUM RISEDRONATE, AND APPLICATION THEREOF | Xiamen Innovax Biotech Co., Ltd. | LY, KRISTINA ELISABETH | 1671 | §103 | Final Rejection | 40d | Pending | May 16, 2023 |
| 18316828 | CASTRATION RESISTANT PROSTATE CANCER | Targimmune Therapeutics AG | LIPPOLIS, ALEXANDRA ROSE | 1637 | §101§103 | Final Rejection | 31d overdue | Pending | May 12, 2023 |
| 18251006 | USE OF ANTI-TREM1 NEUTRALIZING ANTIBODIES FOR THE TREATMENT OF MOTOR NEURON NEURODEGENERATIVE DISORDERS | UCB Biopharma SRL | HUYNH, PHUONG N | 1641 | §102§103§112Other | Final Rejection | — | Pending | Apr 28, 2023 |
| 18250010 | ANTI-CD73 ANTIBODY AND USE THEREOF | Akeso Pharmaceuticals, Inc. | SKELDING, ZACHARY S | 1644 | §102§112DP | Final Rejection | — | Pending | Apr 21, 2023 |
| 18300994 | METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS | Lonza Walkersville, Inc. | MCCORMICK, CATHERINE LYNN | 1638 | §103Other | Non-Final OA | — | Pending | Apr 14, 2023 |
| 18248651 | BINDING MOLECULES THAT MULTIMERISE CD45 | UCB Biopharma SRL | OUSPENSKI, ILIA I | 1644 | §102§103§112 | Non-Final OA | 33d | Pending | Apr 11, 2023 |
| 18246301 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | Lonza Sales AG | BREWSTER, HAYDEN R | 1779 | §103 | Final Rejection | 44d overdue | Pending | Mar 22, 2023 |
| 18246312 | PROCESS FOR PREPARING EXTRACELLULAR VESICLES | Lonza Sales AG | ROYCE, LIAM A | 1777 | §103 | Final Rejection | 7d | Pending | Mar 22, 2023 |
| 18245739 | SHAVING COMPOSITION | Fallien Cosmeceuticals, Ltd. | PRAGANI, RAJAN | 1614 | §102§103§112 | Final Rejection | — | Pending | Mar 17, 2023 |
| 18245687 | HOST CELLS OVEREXPRESSING TRANSLATIONAL FACTORS | LONZA LTD | HOLLAND, PAUL J | 1656 | §103§112 | Final Rejection | — | Pending | Mar 16, 2023 |
| 18024927 | COMPOSITION CONTAINING AMMONIUM POLYPHOSHATE | Chemische Fabrik Budenheim Kg | USELDING, JOHN E | 1763 | §103 | Non-Final OA | — | Pending | Mar 06, 2023 |
| 18164952 | Covalent Diabodies and Uses Thereof | Macrogenics, Inc. | DUFFY, BRADLEY | 1643 | §103 | Final Rejection | 23d | Pending | Feb 06, 2023 |
| 18158767 | METHODS FOR TREATMENT OF SUBJECTS WITH PLAQUE PSORIASIS OF THE SCALP | Sun Pharmaceutical Industries, Ltd. | DONOGHUE, BRITTNEY ERIN | 1675 | §103 | Final Rejection | 88d overdue | Pending | Jan 24, 2023 |
| 18098985 | CREATION OF A HEALTHIER PATELLOFEMORAL JOINT | Episurf Ip-Management AB | LIN, JESSICA YIFANG | 1687 | §103 | Final Rejection | — | Pending | Jan 19, 2023 |
| 17999288 | SERUM-FREE INDUCTION METHOD FOR SENSORY NEURON CELL | Iregene Therapeutics Ltd. | ROGERS, ERIC JASON | 1638 | §112 | Final Rejection | 14d | Pending | Jan 18, 2023 |
| 18005917 | STIMULATION ARRANGEMENTS, VENTILATION ARRANGEMENT, STIMULATION METHODS AND VENTILATION METHOD | Stimit AG | REDDY, SUNITA | 3791 | §103§112 | Non-Final OA | 43d overdue | Pending | Jan 18, 2023 |
| 18005543 | CELL-PENETRATING PEPTIDE AND USE THEREOF | Xiamen University | JAUHARI, SACHI | 1654 | §101§112 | Final Rejection | — | Pending | Jan 13, 2023 |
| 18005438 | EXQUISITE VEGAN CONVENIENCE FOODS AND PRODUCTION THEREOF | Othmar Kaeppeli | MERCHLINSKY, JOSEPH CULLEN | 1791 | §102§103 | Final Rejection | 56d overdue | Pending | Jan 13, 2023 |
| 18090171 | SEALING DEVICE FOR A GAS SORPTION ROTOR OF AN AIR TREATMENT SYSTEM AND A GAS SORPTION ROTOR ARRANGEMENT FOR AN AIR TREATMENT SYSTEM | Munters Corporation | MCKENZIE, THOMAS B | 1776 | §103§112 | Final Rejection | 6d | Pending | Dec 28, 2022 |
| 18063982 | METHODS FOR PRODUCING IMMUNE CELL CULTURES | Lonza Walkersville, Inc. | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Non-Final OA | — | Pending | Dec 09, 2022 |
| 18001025 | Use of Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | Nottingham Trent University | GODDARD, LAURA B | 1642 | §112 | Final Rejection | 22d overdue | Pending | Dec 07, 2022 |
| 18000546 | METHOD OF MAKING VIRUS-LIKE PARTICLE | Icosavax, Inc. | ANTHOPOLOS, PETER | 1611 | §103§112 | Non-Final OA | 26d | Pending | Dec 02, 2022 |
| 17990596 | MIXED ULTRASOUND TRANSDUCER ARRAYS | Deepsight Technology, Inc. | FERNANDEZ, KATHERINE L | 3798 | §103Other | Final Rejection | 55d | Pending | Nov 18, 2022 |
| 17997804 | REGENTIDE-034 AND COMPOSITION FOR IMPROVING CONDITION OF SKIN, CONTAINING SAME | Ninebiopharm Co., Ltd. | AUDET, MAURY A | 1654 | §101 | Final Rejection | — | Pending | Nov 02, 2022 |
| 17997266 | METHODS AND KITS FOR DETECTING ADENO-ASSOCIATED VIRUSES | Lonza Houston, Inc. | ALAM, DANYAL HASSAN | 1672 | §103§112 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17921915 | APPARATUS FOR THE AUTOMATED DIAGNOSTIC ANALYSIS OF LIQUID SAMPLES | Diasys Technologies S.A.R.L. | HERBERT, MADISON TAYLOR | 1758 | §103 | Final Rejection | — | Pending | Oct 27, 2022 |
| 18050017 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103DP | Non-Final OA | — | Pending | Oct 26, 2022 |
| 17917410 | STIMULATION ARRANGEMENT AND METHOD OF OPERATING SUCH STIMULATION ARRANGEMENT | Stimit AG | MATTHEWS, CHRISTINE HOPKINS | 3791 | §102§112 | Final Rejection | 9d | Pending | Oct 06, 2022 |
| 17936020 | METHODS FOR PROCESSING AND ANALYZING EXTRACELLULAR VESICLES | Exosomics Spa | MARCSISIN, ELLEN JEAN | 1677 | §103Other | Non-Final OA | 1d overdue | Pending | Sep 28, 2022 |
| 17952439 | STANDARDIZED IMPLANT WITH INDIVIDUALIZED GUIDE TOOL | Episurf Ip-Management AB | BATES, DAVID W | 3799 | §103 | Final Rejection | 34d | Pending | Sep 26, 2022 |
| 17907116 | AUTONOMOUS KNOB DOMAIN PEPTIDES | UCB Biopharma SRL | ALFANO, ALAN | 1641 | §112 | Final Rejection | 4d overdue | Pending | Sep 23, 2022 |
| 17904346 | PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCH | Leadxpro AG | DEBERRY, REGINA M | 1647 | §112 | Final Rejection | — | Pending | Aug 16, 2022 |
| 17760241 | RECOVERY OF VANADIUM FROM ALKALINE SLAG MATERIALS | Avanti Materials Ltd. | PULLEN, NIKOLAS TAKUYA | 1733 | §103 | Final Rejection | 28d | Pending | Aug 05, 2022 |
| 17795344 | TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERY | Isola Therapeutics, Inc. | TAYLOR, MARISSA ENVENESIA | 3783 | §103 | Final Rejection | 22d | Pending | Jul 26, 2022 |
| 17758234 | MULTIMERIZATION DELIVERY SYSTEM FOR INTRACELLULAR DELIVERY OF MOLECULE | Xiamen Innovax Biotech Co., Ltd. | REGLAS, GEORGIANA C | 1651 | §112Other | Final Rejection | — | Pending | Jun 30, 2022 |
| 17776932 | METHODS OF CELL SELECTION | LONZA LTD | LEVIN, JOEL D | 1633 | §103 | Final Rejection | 29d | Pending | May 13, 2022 |
| 17769118 | RESPIRATION PROMOTING APPARATUS AND USE THEREOF | Stimit AG | KOHUTKA, BROOKE NICOLE | 3791 | §103 | Final Rejection | — | Pending | Apr 14, 2022 |
| 17768610 | End-to-End Platform for Human Pluripotent Stem Cell Manufacturing | Lonza Walkersville, Inc. | ROGERS, ERIC JASON | 1638 | §103§112 | Final Rejection | 49d | Pending | Apr 13, 2022 |
| 17635638 | PROCESS CONTROL SYSTEMS FOR AUTOMATED CELL ENGINEERING SYSTEMS | Octane Biotech Inc. | SINES, BRIAN J | 1796 | §102§103 | Final Rejection | 10d overdue | Pending | Feb 15, 2022 |
| 17635315 | EXTRACELLULAR VESICLES WITH STAT3-ANTISENSE OLIGONUCLEOTIDES | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103 | Final Rejection | — | Pending | Feb 14, 2022 |
| 17635322 | EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6 | Lonza Sales AG | TRAN, CHRISTINA L | 1637 | §103§112DP | Final Rejection | 7d | Pending | Feb 14, 2022 |
| 17635298 | EXTRACELLULAR VESICLES WITH ANTISENSE OLIGONUCLEOTIDES TARGETING KRAS | Lonza Sales AG | ALLEN, SARAH ELIZABETH | 1637 | §102§103§112 | Non-Final OA | 47d | Pending | Feb 14, 2022 |
| 17666215 | IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER | ETH ZÜRICH | HOPPE, EMMA RUTH | 1683 | §101 | Final Rejection | 14d | Pending | Feb 07, 2022 |
| 17626351 | COMPLEX FOR INTRACELLULAR DELIVERY OF MOLECULES | Xiamen Innovax Biotech Co., Ltd. | JONES, DAMERON LEVEST | 1618 | §112Other | Non-Final OA | — | Pending | Jan 11, 2022 |
| 17562316 | METHOD FOR CONTROLLING AN EYE SURGICAL LASER, COMPUTER PROGRAM PRODUCT, AND TREATMENT APPARATUS | Schwind Eye-Tech-Solutions GmbH | CHRISTIANSON, SKYLAR LINDSEY | 3792 | §102§112 | Non-Final OA | 282d overdue | Pending | Dec 27, 2021 |
| 17620615 | METHOD FOR SEPARATING NUCLEIC ACID MOLECULES BY SIZE | Qiagen GmbH | LAFAVE, ELIZABETH ROSE | 1684 | §102§103Other | Final Rejection | — | Pending | Dec 17, 2021 |
| 17603921 | Methods for Treatment of Subjects with Psoriatic Arthritis | Sun Pharmaceutical Industries, Ltd. | FORD, VANESSA L | 1674 | §112 | Non-Final OA | — | Pending | Oct 14, 2021 |
| 17594054 | IMMUNOTHERAPY FOR THE TREATMENT OF CANCER | Targimmune Therapeutics AG | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103§112DP | Non-Final OA | — | Pending | Sep 30, 2021 |
| 17402730 | COMPOSITIONS COMPRISING SHORT-ACTING BENZODIAZEPINES | Paion UK Limited | MCDOWELL, BRIAN E | 1624 | §103 | Final Rejection | 12d | Pending | Aug 16, 2021 |
| 17426832 | ABUTMENT ARRANGEMENT AND DENTAL RESTORATION KIT | Institut Straumann AG | RUIZ MARTIN, LUIS MIGUEL | 3772 | §103 | Final Rejection | 9d overdue | Pending | Jul 29, 2021 |
| 17344792 | METHOD FOR ISOLATING POLY(A) NUCLEIC ACIDS | Qiagen GmbH | HANEY, AMANDA MARIE | 1682 | §103§112 | Non-Final OA | 42d overdue | Pending | Jun 10, 2021 |
| 17338408 | ENHANCED PRODUCTION OF IMMUNOGLOBULINS | Trianni, Inc. | NICOL, ALEXANDER W | 1634 | §103§112 | Non-Final OA | 61d | Pending | Jun 03, 2021 |
| 17293833 | ENGINEERED EXTRACELLULAR VESICLES AND USES THEREOF | Lonza Sales AG | ESPINOSA, CLAUDIA EDILMA | 1654 | §103§112DP | Final Rejection | 13d | Pending | May 13, 2021 |
| 17290061 | Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | Nottingham Trent University | SITTON, JEHANNE SOUAYA | 1682 | §101 | Final Rejection | 88d overdue | Pending | Apr 29, 2021 |
| 17136165 | CLEAR LACROSSE HEAD | East Coast Dyes, Inc. | KLAYMAN, AMIR ARIE | 3711 | §103§112 | Final Rejection | — | Pending | Dec 29, 2020 |
| 17112319 | METHOD FOR DETERMINING A CURRENT POSITION OF A PATIENT INTERFACE OF AN EYE SURGICAL LASER BASED ON A PURKINJE IMAGE | Schwind Eye-Tech-Solutions GmbH | ANJARIA, SHREYA PARAG | 3796 | §103 | Non-Final OA | 44d overdue | Pending | Dec 04, 2020 |
| 15549394 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE | Entera Bio Ltd. | REYNOLDS, FRED H | 1658 | §103Other | Final Rejection | — | Pending | Aug 08, 2017 |
